- S&P 500 Futures drop for the third day after rising to three week high earlier in the week.
- UK Government pushes for AstraZeneca’s fast-track approval after news of an extra trial.
- Trump said the vaccine will be delivered starting next week.
- Virus/vaccine updates and trade/political tussles among key economies should be watched amid a light calendar.
S&P 500 Futures drops 0.30% to 3,617 amid the initial hour of Tokyo open on Friday. The risk barometer declines for the third consecutive day amid mixed signals over the coronavirus (COVID-19) vaccines. Also challenging the mood could be the fears of further escalation in the virus cases before the cure hit the floor.
The UK Government is pushing the Medicines and Healthcare Products Regulatory Agency (MHRA) to assess Oxford/AstraZeneca covid-19 vaccine for a temporary supply. The reason could be traced from the British drug manufacturer’s announcement on Thursday that they’re holding one more trial amid some production issues over the less-dosage vaccine.
On the positive side, US President Donald Trump said that the vaccine will be delivered from next week. It should be noted that the latest covid number from Texas and California have been worrisome.
Elsewhere, the US-China and the Washington-Tehran tensions have recently been challenging the optimists trying to cheer the vaccine hopes and the expectations of the US recovery backed by the new government team.
That said, the US 10-year Treasury yields drop 3.3 basis points (bps), to currently around 0.84%, whereas stocks in Asia-Pacific trade mixed.
Looking forward, a lack of major data/events can extend the previous day’s inactive mood, led by the US Thanksgiving Day. Though, fresh challenges to the risk can help the market trim earlier gains.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
EUR/USD clings to modest gains above 1.0650 ahead of US data
EUR/USD trades modestly higher on the day above 1.0650 in the early American session on Tuesday. The upbeat PMI reports from the Eurozone and Germany support the Euro as market focus shift to US PMI data.
GBP/USD extends rebound, tests 1.2400
GBP/USD preserves its recovery momentum and trades near 1.2400 in the second half of the day on Tuesday. The data from the UK showed that the private sector continued to grow at an accelerating pace in April, helping Pound Sterling gather strength against its rivals.
Gold flirts with $2,300 amid receding safe-haven demand
Gold (XAU/USD) remains under heavy selling pressure for the second straight day on Tuesday and languishes near its lowest level in over two weeks, around the $2,300 mark in the European session. Eyes on US PMI data.
Here’s why Ondo price hit new ATH amid bearish market outlook Premium
Ondo price shows no signs of slowing down after setting up an all-time high (ATH) at $1.05 on March 31. This development is likely to be followed by a correction and ATH but not necessarily in that order.
US S&P Global PMIs Preview: Economic expansion set to keep momentum in April
S&P Global Manufacturing PMI and Services PMI are both expected to come in at 52 in April’s flash estimate, highlighting an ongoing expansion in the private sector’s economic activity.